What is a stock summary page? Click here for an overview.
Business Description
Indo US Bio-Tech Ltd
ISIN : INE250Z01010
Share Class Description:
NSE:INDOUS: Ordinary SharesCompare
Compare
Traded in other countries / regions
541304.India IPO Date
2024-09-27Description
Indo US Bio-Tech Ltd is engaged in the trading of agricultural seeds. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of agriculture crops. The company's product categories include vegetables; cotton seeds; oilseeds; spices seeds; pulses seeds and cereals seeds. The company has two segments which include Agricultural Activities and Trading Activities out of which it generates the key revenue from the Agricultural Activities.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.07 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.22 | |||||
| Debt-to-EBITDA | 1.29 | |||||
| Interest Coverage | 10.74 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 13.61 | |||||
| Beneish M-Score | -1.43 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 9.7 | |||||
| 3-Year EBITDA Growth Rate | 14.6 | |||||
| 3-Year EPS without NRI Growth Rate | 6.8 | |||||
| 3-Year FCF Growth Rate | -42.8 | |||||
| 3-Year Book Growth Rate | 9.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 54.11 | |||||
| 9-Day RSI | 41.35 | |||||
| 14-Day RSI | 37.38 | |||||
| 3-1 Month Momentum % | -24.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.74 | |||||
| Quick Ratio | 2.52 | |||||
| Cash Ratio | 0.08 | |||||
| Days Inventory | 263.34 | |||||
| Days Sales Outstanding | 153.38 | |||||
| Days Payable | 21.72 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.15 | |||||
| Dividend Payout Ratio | 0.05 | |||||
| Forward Dividend Yield % | 0.15 | |||||
| 5-Year Yield-on-Cost % | 0.15 | |||||
| 3-Year Average Share Buyback Ratio | -11.3 | |||||
| Shareholder Yield % | -0.07 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.58 | |||||
| Operating Margin % | 20.17 | |||||
| Net Margin % | 16.16 | |||||
| FCF Margin % | -11.69 | |||||
| ROE % | 17.93 | |||||
| ROA % | 13.45 | |||||
| ROIC % | 17.28 | |||||
| 3-Year ROIIC % | 22.6 | |||||
| ROC (Joel Greenblatt) % | 17.54 | |||||
| ROCE % | 18.77 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 34.67 | |||||
| PE Ratio without NRI | 34.67 | |||||
| Shiller PE Ratio | 59.13 | |||||
| PEG Ratio | 1.27 | |||||
| PS Ratio | 5.59 | |||||
| PB Ratio | 4.88 | |||||
| Price-to-Tangible-Book | 4.9 | |||||
| EV-to-EBIT | 31.76 | |||||
| EV-to-EBITDA | 30.35 | |||||
| EV-to-Revenue | 5.8 | |||||
| EV-to-FCF | -47.67 | |||||
| Price-to-GF-Value | 2.69 | |||||
| Price-to-DCF (Earnings Based) | 1.33 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.67 | |||||
| Price-to-Graham-Number | 2.72 | |||||
| Price-to-Net-Current-Asset-Value | 5.86 | |||||
| Earnings Yield (Greenblatt) % | 3.14 | |||||
| FCF Yield % | -2.1 | |||||
| Forward Rate of Return (Yacktman) % | 18.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Indo US Bio-Tech Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 615.024 | ||
| EPS (TTM) (₹) | 4.93 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 37.38 | ||
| 14-Day ATR (₹) | 11.033354 | ||
| 20-Day SMA (₹) | 180.0805 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 150 - 388.4 | ||
| Shares Outstanding (Mil) | 20.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Indo US Bio-Tech Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Indo US Bio-Tech Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Indo US Bio-Tech Ltd Frequently Asked Questions
What is Indo US Bio-Tech Ltd(NSE:INDOUS)'s stock price today?
The current price of NSE:INDOUS is ₹170.84. The 52 week high of NSE:INDOUS is ₹388.40 and 52 week low is ₹150.00.
When is next earnings date of Indo US Bio-Tech Ltd(NSE:INDOUS)?
The next earnings date of Indo US Bio-Tech Ltd(NSE:INDOUS) is .
Does Indo US Bio-Tech Ltd(NSE:INDOUS) pay dividends? If so, how much?
The Dividend Yield %  of Indo US Bio-Tech Ltd(NSE:INDOUS) is 0.15% (As of Today), Highest Dividend Payout Ratio of Indo US Bio-Tech Ltd(NSE:INDOUS) was 0.05. The lowest was 0.02. And the median was 0.02. The  Forward Dividend Yield % of Indo US Bio-Tech Ltd(NSE:INDOUS) is 0.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers